Zynerba Pharma Stock Price (NASDAQ:ZYNE)

Add to My Stocks
$6.13 $0.15 (2.39%) ZYNE stock closing price Aug 20, 2018 (Closing)
Prev Close* : $6.28
Market Cap:
Day Low: $6.01
52 Week Low: $5.59
Open: $6.28
Volume: -
Day High: $6.34
52 Week High: $15.14

Latest Stock Market News

Latest Articles

Zynerba Pharma News - From Partners

ZYNE Stockcharts

View ZYNE PE ratio, PS ratio stocks charts and compare with peers.
ZYNE Chart
Note: Compare Zynerba Pharma stock price history with the index and industry peers.

Zynerba Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Zynerba Pharma Returns

(return on equity)

Zynerba Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

ZYNE Industry Peers

Company Price Change (%)
Teligent (TLGT)4.260 (0%)
Sol Gel Tech (SLGL)6.20.1 (1.59%)
Nemus Bioscience (NMUS)0.20 (0%)
Pfizer (PFE)42.330.24 (0.57%)
Marinus Pharma (MRNS)5.620.05 (0.9%)
Eli Lilly (LLY)105.820.27 (0.26%)
Pfizer (PFE)42.330.24 (0.57%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teva Pharmaceutical (TEVA)25.651.43 (5.9%)
Mallinckrodt (MNK)36.071.38 (3.98%)
Allergan (AGN)190.755.15 (2.77%)
Akorn (AKRX)19.480.49 (2.58%)
BAUSCH HEALTH (BHC)22.320.43 (1.96%)
Dr. Reddy's Laboratories (RDY)34.220.39 (1.15%)
Mylan (MYL)38.410.26 (0.68%)
Top gainers from Medical-Generic Drugs industry
* As of Aug 21, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)21.840.59 (2.63%)
Progenics Pharma (PGNX)7.670.14 (1.79%)
Supernus Pharma (SUPN)44.40.4 (0.89%)
Corium (CORI)8.890.04 (0.45%)
Top losers from Medical-Generic Drugs industry
* As of Aug 21, 2018

Zynerba Pharmaceuticals Inc Stock News - Partner Headlines

Zynerba Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-32.01M-23.38M-12.55M-5.66M-0.63M
Total Operating Expense32.81M23.21M12.8M6.47M1.13M
View Zynerba Pharma income statement
balance sheet20172016201520142013
Total Assets69.05M36.55M43.64M11.61M1.86M
Total Liabilities8.1M6.96M3.93M3.14M3.05M
Shareholders Equity60.94M29.58M39.7M8.47M-1.19M
View Zynerba Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--0.49M1.13M--
Net Cash from (used by) Operating Activities-25.84M-20.43M-9.78M-3.54M-0.11M
Increase (Decrease) in Prop Plant And Equipment-0.11M-0.1M-0.21M-0.01M-
View Zynerba Pharma cash flow statement

Zynerba Pharma Stock Message Board

An investor needs to spend $6.13 to buy ZYNE stock, as the closing Zynerba Pharma stock price is $6.13. The total market value as denoted by $110.68M for Zynerba Pharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Zynerba Pharma stock analysis.

For recognizing and analyzing the real performance of Zynerba Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 309,327 shares were traded with a closing stock price of $6.13 as of Aug 20, 2018, as can be seen from Zynerba Pharma stock quote. One can view Zynerba Pharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Zynerba Pharma dividend per share was 0.00 during the last quarter. Zynerba Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.